AI biotech founded by ex-Google CEO Eric Schmidt is raising $150 million Hologen, which uses AI to optimize late-stage clinical trials, has ambitious financial goals

https://www.statnews.com/2026/01/28/hologen-ai-biotech-startup-series-a-fundraise/ By Brittany TrangJan. 28, 2026 Health Tech Reporter